Patent AT-E400276-T1: [Translated] NON-NUCLEOSIDIC REVERSE TRANSCRIPTASE INHIBITORS AS ANTAGONISTS OF CELL PROLIFERATION AND INDUCTORS OF CELL DIFFERENTIATION
Description
Chemical patent from PubChem database. Patent Number: AT-E400276-T1. Title: Novel Pharmaceutical Composition. Filing Date: 1998-02-08. Inventors: Anderson, Robert, Davis, Linda. Abstract: The present invention relates to a novel pharmaceutical composition comprising one or more active pharmaceutical ingredients and pharmaceutically acce... IPC Classifications: C07D, A61K, A61P. This patent covers 32 claims related to 8 chemical compounds. Useful for intellectual property research, prior art searches, and chemical innovation tracking.
Resources
| Name |
Format |
Description |
Link |
|
21 |
Access the complete Patent AT-E400276-T1: [Translated] NON-NUCLEOSIDIC REVERSE TRANSCRIPTASE INHIBITORS AS ANTAGONISTS OF CELL PROLIFERATION AND INDUCTORS OF CELL DIFFERENTIATION on the official website. |
https://pubchem.ncbi.nlm.nih.gov/patent/AT-E400276-T1 |
Tags
- patent
- chemistry
- research
- innovation
- pubchem